NICOTINE MINI- nicotine polacrilex lozenge 
Advagen Pharma Limited

----------

Drugs Facts


Active ingredient (in each lozenge)

Nicotine polacrilex 4 mg

Nicotine polacrilex 2 mg


Purpose

Stop smoking aid


Use


Warnings

If you are pregnant or breast-feeding,

only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.


Ask a doctor before use if you have


Ask a doctor or pharmacist before use if you are


Stop use and ask a doctor if


Keep out of reach of children and pets.

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.


Directions (4 mg lozenge)

Weeks 1 to 6 Weeks 7 to 9 Weeks 10 to 12
1 lozenge every 1 to 2
hours
1 lozenge every 2 to 4
hours
1 lozenge every 4 to 8
hours

Directions (2 mg lozenge)

Weeks 1 to 6 Weeks 7 to 9 Weeks 10 to 12
1 lozenge every 1 to 2
hours
1 lozenge every 2 to 4
hours
1 lozenge every 4 to 8
hours

Other information


Inactive ingredients

acesulfame potassium, colloidal silicon dioxide, flavors, hydroxypropyl cellulose, magnesium stearate, mannitol, potassium bicarbonate, povidone, sodium alginate, sodium carbonate, sucralose, and xanthan gum.


Questions or comments?

Call 866-488-0312 Monday-Friday 9AM-5PM EST


Manufactured by

Rubicon Research Pvt. Ltd
Ambernath, Maharashtra 421 506, India


Manufactured for

Advagen Pharma Limited,
666 Plainsboro Road, Suite 605
Plainsboro, NJ 08536, USA


Revised - April 2023

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Label

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Label

nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Container Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Container Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 27s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-54 - 81s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 81s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-55 - 108s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 108s Carton Label

Nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-56 - 135s Carton Label

nicotine Polacrilex Lozenge, 4 mg - NDC 72888-187-53 - 135s Carton Label

NICOTINE MINI 
nicotine polacrilex lozenge
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72888-186
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE2 mg
Inactive Ingredients
Ingredient NameStrength
ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MANNITOL (UNII: 3OWL53L36A)  
POTASSIUM BICARBONATE (UNII: HM5Z15LEBN)  
POVIDONE (UNII: FZ989GH94E)  
SODIUM ALGINATE (UNII: C269C4G2ZQ)  
SODIUM CARBONATE (UNII: 45P3261C7T)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
XANTHAN GUM (UNII: TTV12P4NEE)  
Product Characteristics
Colorwhite (White to Off-white) Scoreno score
ShapeOVALSize11mm
FlavorMINTImprint Code A516
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72888-186-531 in 1 CARTON04/14/2023
127 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:72888-186-543 in 1 CARTON04/14/2023
227 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:72888-186-554 in 1 CARTON04/14/2023
327 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:72888-186-565 in 1 CARTON04/14/2023
427 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20887504/14/2023
NICOTINE MINI 
nicotine polacrilex lozenge
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72888-187
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE4 mg
Inactive Ingredients
Ingredient NameStrength
ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MANNITOL (UNII: 3OWL53L36A)  
POTASSIUM BICARBONATE (UNII: HM5Z15LEBN)  
POVIDONE (UNII: FZ989GH94E)  
SODIUM ALGINATE (UNII: C269C4G2ZQ)  
SODIUM CARBONATE (UNII: 45P3261C7T)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
XANTHAN GUM (UNII: TTV12P4NEE)  
Product Characteristics
Colorwhite (White to Off-white) Scoreno score
ShapeOVALSize11mm
FlavorMINTImprint Code A435
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72888-187-531 in 1 CARTON04/14/2023
127 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:72888-187-543 in 1 CARTON04/14/2023
227 in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:72888-187-554 in 1 CARTON04/14/2023
327 in 1 BOTTLE; Type 0: Not a Combination Product
4NDC:72888-187-565 in 1 CARTON04/14/2023
427 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20887504/14/2023
Labeler - Advagen Pharma Limited (051627256)
Establishment
NameAddressID/FEIBusiness Operations
Rubicon Research Private Limited677604197analysis(72888-186, 72888-187) , label(72888-186, 72888-187) , manufacture(72888-186, 72888-187)

Revised: 4/2023
Document Id: fa622dd8-8c65-8e19-e053-6294a90a23cc
Set id: 7f124912-7ce8-4b9f-8458-46b68362f47d
Version: 1
Effective Time: 20230428
 
Advagen Pharma Limited